Synthesis, biodistribution and renal handling of various chelate- somatostatin conjugates with metabolizable linking groups

Nuclear Medicine and Biology

Volumn 24, Issue 8, 1997, Pages 761-769

  Smith Jones, Peter M ^a,b   Stolz, Barbara ^a   Albert, Rainer ^a   Knecht, Hellmut ^a   Bruns, Christian ^a  

^a Preclinical Research   (Switzerland)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Indium 111; Kidney; Linkers; Octreotide

Indexed keywords

INDIUM 111; OCTREOTIDE; PENTETIC ACID; PENTETREOTIDE; PENTETREOTIDE IN 111; SDZ 105; SDZ 171; SDZ 468; SDZ 520; SDZ 547; SDZ 595; SDZ 610; SDZ 731; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG SYNTHESIS; ISOTOPE LABELING; KIDNEY CLEARANCE; KIDNEY HOMOGENATE; MALE; MEMBRANE BINDING; NONHUMAN; RAT;

ANIMALS; CHELATING AGENTS; CROSS-LINKING REAGENTS; DRUG STABILITY; ENZYME STABILITY; INDIUM RADIOISOTOPES; KIDNEY; MALE; PENTETIC ACID; RATS; RATS, INBRED LEW; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TISSUE DISTRIBUTION; YTTRIUM RADIOISOTOPES;

EID: 0030657572     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00112-1     Document Type: Article

References (32)

1. Albert R., Marbach P., Bauer W., et al. (1991) SDZ CO 611: A highly potent glycated analog of somatostatin with improved oral activity. Life Sci. 53, 517-525.
2. Arano Y., Wakisaka K., Mukai T., et al. (1996) Stability of a metabolizable ester bond in radioimmunoconjugates. Nucl. Med. Biol. 23, 129-136.
3. 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: Synthesis, radiolabelling and in vitro evaluation. Life Sci. 49, 1583-1591.
4. Bauer W., Briner U., Doepfner W., et al. (1982) SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 31, 1133-1141.
5. Behr T. M., Sharkey R. M., Juweid M. E., et al. (1995) Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res. 55, 3825-3834.
6. Brechbiel W. M., Gansow O. A., Atcher R. W., et al. (1986) Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA: Antibody labeling and tumor-imaging studies. Inorg. Chem. 25, 2272-2781.
7. Bruns C., Dietl M., Palacios J. and Pless J. (1990) Identification and characterization of somatostatin receptors in neonatal rat long bones. Biochem. J. 265, 39-44.
8. Carone F. A. and Peterson D. R. (1980) Hydrolysis and transport of small peptides by the proximal tubule. J. Physiol. 238, F151-F158.
9. Carone F. A., Peterson D. R. and Flouret G. (1982) Renal tubular processing of small peptide hormones. J. Lab. Clin. Med. 100, 1-14.
10. Christensen E. J. and Maunsbach A. B. (1974) Intralysosomal digestion of lysozyme in renal proximal tubule cells. Kidney Int. 6, 396-407.
11. Cole W. C., DeNardo S. J., Meares C. F., et al. (1987) Comparative serum stability of radiochelates for antibody radiopharmaceuticals. J. Nucl. Med. 28, 83-90.
12. 111In-DTPA octreotide (OctreoScan®111) in vivo in the rat. J. Nucl. Med. 35, 165.
13. Deshpande S., DeNardo S., Meares C., et al. (1989) Effect of different linkages between chelates and monoclonal antibodies on levels of radioactivity in the liver. Nucl. Med. Biol. 16, 587-597.
14. 2 fragments of anti-carcinoembryonic antigen. II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice. Nucl. Med. Biol. 20, 763-771.
15. Fransen E., Koiter J., Kuipers C., et al. (1992) Low molecular weight proteins as carriers for renal drug targeting: Preparation of drug-protein conjugates and drug spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates. J. Med. Chem. 35, 1246-1259.
16. Fransen E., van Amsterdam R., Visser J., et al. (1991) Low molecular weight proteins as carriers for renal drug targeting: Naproxen-lysozyme. Pharmacol. Res. 8, 1223-1230.
17. 2 fragments of anti-carcinoembryonic antigen. I. A new reproducible synthetic method. Nucl. Med. Biol. 20, 755-762.
18. Hajri A., Bruns C., Marbach P., et al. (1991) Inhibition of the growth of transplanted rat pancreatic acinar carcinoma with Octreotide. Eur. J. Cancer 27, 1247-1252.
19. Hammond P. J., Wade A. F., Gwilliam M. E., et al. (1993) Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue. Br. J. Cancer 67, 1437-1439.
20. 111In chelate conjugated anti-idiotype monoclonal antibody for cardioimmunodetection of lymphoma in mice. Eur. J. Nucl. Med. 12, 455-460.
21. 3]-octreotide: The Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med. 20, 716-731.
22. Maak T., Johnson V., Kau S. T., et al. (1979) Renal filtration, transport and metabolism of low molecular weight proteins: A review. Kidney Int. 16, 251-270.
23. Maecke H. R., Riesen A. and Ritter W. (1989) The molecular structure of indium-DTPA. J. Nucl. Med. 30, 1235-1239.
24. Meares C., McCall M., Despande S., et al. (1988) Chelate radiochemistry: Cleavable linkers lead to altered levels of radioactivity in the liver. Int. J. Cancer 42(Suppl. 2), 99-102.
25. Mogensen C. E. and Sølling K. (1977) Studies on renal tubular protein reabsorption: Partial and near complete inhibition by certain amino acids. Scand. J. Clin. Invest. 37, 477-486.
26. 111In-DTPA to accelerate clearance from nontarget organs and blood. Nucl. Med. Biol. 16, 475-481.
27. Paik C., Yokoyama K., Reynolds J., et al. (1989) Reduction of background activities by introduction of a diester linkage between antibody and a chelate in radioimmunodetection of tumor. J. Nucl. Med. 30, 1693-1701.
28. Renard C., Michel A. and Tulkens P. M. (1986) Hydrolysis of Pro-Ala dipeptides by lyosomal hydrolyses: Models for the study of lyosomaotropic amino acid prodrugs of penicillins. J. Med. Chem. 29, 1291-1293.
29. Reubi J. C. (1985) New specific radioligand for one subpopulation of brain somatostatin receptots. Life Sci. 36, 1829-1836.
30. 90Y]-SDZ 413: A yttrium-90 labeled octreotide analogue for radiotherapy of somatostatin receptor positive tumours. Nucl. Med. Biol. (in press).
31. Stolz B., Smith-Jones P. M., Hofmann G., et al. (1997) Reduction of renal uptake of octreotide analogues (manuscript in preparation).
32. Studer M., Kroger L., DeNardo S., Kukis D. and Meares C. (1992) Influence of a peptide linker on biodistribution and metabolism of antibody-conjugated benzyl-EDTA: Comparison of enzymatic digestion in vitro and in vivo. Bioconjug. Chem. 3, 424-429.